Trials / Unknown
UnknownNCT05562206
CGMIS 48-hour Feasibility Study
A 48hr Study to Test Feasibility of the Pacific Diabetes Technologies Continuous Glucose Monitor Infusion Set (CGMIS) Sensing Interstitial Glucose Continuously in the Immediate Vicinity of SQ Insulin Delivery in Adults With T1 Diabetes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Pacific Diabetes Technologies · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, single arm non-randomized study of 48-hour CGMIS wear duration incorporating two meal-challenge tests to explore the performance of a single insertion combined glucose-sensing insulin delivery cannula.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CGMIS (Continuous Glucose Monitoring Infusion Set) | An integrated combination CGM/insulin infusion system |
Timeline
- Start date
- 2022-08-30
- Primary completion
- 2022-10-01
- Completion
- 2022-11-01
- First posted
- 2022-09-30
- Last updated
- 2022-09-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05562206. Inclusion in this directory is not an endorsement.